MRNA Return on Tangible Equity | Moderna, Inc.

Moderna, Inc. (MRNA) Return on Tangible Equity

2026-06-30: Return Tang Equity -47.74%.
2026-03-31: Return Tang Equity -44.12%.
2025-12-31: Return Tang Equity -32.99%.
2025-09-30: Return Tang Equity -33.76%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-47.74%
2026-03-31	-44.12%
2025-12-31	-32.99%
2025-09-30	-33.76%
2025-06-30	-31.22%
2025-03-31	-33.69%
2024-12-31	-32.94%
2024-09-30	-18.79%
2024-06-30	-50.50%
2024-03-31	-46.91%
2023-12-31	-34.26%
2023-09-30	-25.95%
2023-06-30	7.16%
2023-03-31	25.50%
2022-12-31	43.73%
2022-09-30	65.39%
2022-06-30	78.15%
2022-03-31	85.73%
2021-12-31	86.26%
2021-09-30	69.75%
2021-06-30	52.13%
2021-03-31	15.58%
2020-12-31	-29.17%
2020-09-30	-21.64%
2020-06-30	-16.54%
2020-03-31	-30.80%
2019-12-31	-43.74%
2019-09-30	-42.63%
2019-06-30	-36.65%
2019-03-31	-30.85%
2018-12-31	-25.15%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-32.99%
2024-12-31	-32.94%
2023-12-31	-34.26%
2022-12-31	43.73%
2021-12-31	86.26%
2020-12-31	-29.17%
2019-12-31	-43.74%
2018-12-31	-25.15%
2017-12-31	46.41%
2016-12-31	64.58%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Revolution Medicines, Inc. (RVMD)	United States	$42.805B	-22.69
BIOGEN INC. (BIIB)	United States	$33.427B	19.60
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69